BioSpace News Archive

Boundless Bio today announced that it has appointed Neil Abdollahian, as Chief Business Officer.

Immunotherapy May Be Effective for a Subgroup of Metastatic Colorectal Cancer Patients, City of Hope Study Finds

Community Health Centers remain drivers of equity in the fight against COVID, despite the upsurge in the Delta variant

NRx Pharmaceuticals (NRx) (Nasdaq: NRXP), a clinical stage, global biopharmaceutical company today announced it is initiating a phase 2b dose-confirmatory trial of the BriLife™ vaccine against COVID-19 in the Nation of Georgia.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, announced today the availability of a presentation on its corporate website to provide an overview of Sorrento’s proprietary mRNA vaccine development program for COVID-19.

Medline today announced new customer contracts, representing more than 50 hospitals across the U.S., for PrefConnect® , a digital preference card review system to help ensure accurate and complete operating room supply pick lists.

IRIDEX Corporation, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced the Company plans to participate in the upcoming H.C. Wainwright Ophthalmology Virtual Conference.

Turning Point Therapeutics, Inc., a precision oncology company developing next-generation therapies that target genetic drivers of cancer, reported financial results and operational updates for the second quarter ended June 30, 2021.

Design Therapeutics, Inc., a biotechnology company developing treatments for degenerative genetic disorders, reported recent progress with its portfolio of novel small molecule gene targeted chimeras, as well as business highlights and second quarter 2021 financial results.

Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, announced that Doug Drysdale, Chief Executive Officer, will be presenting virtually at Canaccord Genuity’s 41st Annual Growth Conference on August 10, 2021.